Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Budesonide (Zentacort Capsules) safety in Crohn's disease
jRCT1080224091Completed
- Sponsor
- Zeria Pharmaceutical Co., Ltd.
- Start
- Oct 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of budesonide in Crohn's disease, sponsored by Zeria Pharmaceutical Co., Ltd. Started Oct 2018; status: completed.
02
Drugs
budesonide
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on jRCT1080224091.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080224091.